| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $207,027,657 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 000 | 2 | NIH | 3/20/2025 | $376,768 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 001 | 2 | NIH | 5/7/2025 | $29,303 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI186945 | Gene regulatory network of memory B cell and long-lived plasma cell differentiation | 000 | 1 | NIH | 7/3/2025 | $625,348 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23EY032577 | Improving Glaucoma Care Using a Scalable Decision Support System | 000 | 4 | NIH | 2/20/2025 | $270,321 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00MH121563 | Determining the role of amygdalostriatal transition zone circuits in associative learning and motivated behaviors | 000 | 4 | NIH | 2/19/2025 | $211,650 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K24AG080168 | Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring. | 000 | 3 | NIH | 2/19/2025 | $198,213 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR084430 | The role of mechanosensing and mechanotransduction in joint homeostasis and osteoarthritis susceptibility | 000 | 1 | NIH | 7/10/2025 | $691,089 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI188504 | Innate iNKT Cells Shape Organ-Specific Pathogenesis in Plasmodium Infection | 000 | 1 | NIH | 7/17/2025 | $423,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS142383 | Pathophysiologic Nerve Regeneration | 000 | 1 | NIH | 7/10/2025 | $594,115 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31DK141216 | Investigation of the dynamics and mechanisms of colitis-induced neuroinflammation | 000 | 1 | NIH | 6/25/2025 | $40,318 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL175226 | Role of Angiotensin II in Cardiogenic Shock Pathophysiology and Outcomes | 000 | 1 | NIH | 7/17/2025 | $189,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21DC022648 | Neural basis of precedence-type sound localization processes | 000 | 1 | NIH | 3/20/2025 | $189,530 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA249185 | Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications | 004 | 6 | NIH | 7/11/2025 | $352,270 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC021938 | Biomechanical Mechanisms of Benign Paroxysmal Positional Vertigo | 000 | 1 | NIH | 3/19/2025 | $514,546 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R13EB038076 | Medical Imaging with Deep Learning (MIDL) Conference 2025 | 000 | 1 | NIH | 7/4/2025 | $10,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI188073 | A 3-In-One Design of CAR Tregs for Robust Immunotolerance | 000 | 1 | NIH | 6/26/2025 | $423,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $134,417 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $344,663 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $40,284 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH126051 | Neuroplasticity-Based Computerized Cognitive Remediation (nCCR) for Treatment Resistant Late-Life Depression | 000 | 5 | NIH | 2/14/2025 | $1,240,609 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA240612 | Biology and Targeting of noncoding RNAs in AML | 001 | 5 | NIH | 5/22/2025 | $35,227 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA240612 | Biology and Targeting of noncoding RNAs in AML | 000 | 5 | NIH | 3/13/2025 | $317,048 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DE032366 | CranioRate: An imaging-based, deep-phenotyping analysis toolset, repository, and online clinician interface for craniosynostosis | 002 | 3 | NIH | 7/30/2025 | $634,941 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD099487 | Comorbid Disease in Women with Primary Ovarian Insufficiency | 000 | 6 | NIH | 2/1/2025 | $558,419 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 001 | 2 | NIH | 6/13/2025 | $39,101 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 000 | 2 | NIH | 2/25/2025 | $351,923 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH104603 | Deciphering gene-environment interactions in pathological reactive aggression | 000 | 9 | NIH | 3/4/2025 | $626,434 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00EY032119 | Bridging gap in comparative biology using the tree shrew visual system | 000 | 5 | NIH | 2/14/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI185994 | Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice | 000 | 1 | NIH | 2/24/2025 | $224,070 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 001 | 3 | NIH | 6/12/2025 | $38,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 000 | 3 | NIH | 2/21/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL141353 | Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies | 001 | 8 | NIH | 5/20/2025 | $590,741 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1HD087226 | NICHD Cooperative Multicenter Neonatal Research Network - Utah Center | 002 | 10 | NIH | 4/3/2025 | $339,184 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA262788 | Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity | 003 | 4 | NIH | 6/2/2025 | $352,275 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 000 | 2 | NIH | 3/7/2025 | $525,081 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 001 | 8 | NIH | 6/3/2025 | $38,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99DA061935 | Building evidence for effective extended-release buprenorphine treatment for opioid use disorder | 000 | 1 | NIH | 6/26/2025 | $201,960 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 8 | NIH | 3/7/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA252883 | Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia | 000 | 4 | NIH | 3/13/2025 | $289,908 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 001 | 2 | NIH | 5/7/2025 | $40,841 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35DK103596 | MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases | 000 | 10 | NIH | 3/3/2025 | $44,200 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 3 | NIH | 2/13/2025 | $486,185 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 4 | NIH | 2/20/2025 | $149,623 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K22NS123547 | The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection | 003 | 5 | NIH | 7/30/2025 | $273,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24NS107156 | The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT) | 002 | 8 | NIH | 6/12/2025 | $423,100 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 001 | 3 | NIH | 5/12/2025 | -$28,247 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 000 | 3 | NIH | 2/19/2025 | $43,133 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3NS132134 | A reference-free computational algorithm for comprehensive somatic mosaic mutation detection | 000 | 3 | NIH | 7/25/2025 | $599,608 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL174545 | Roles for SGK1 in Cardiometabolic Heart Failure with Preserved Ejection Fraction | 000 | 1 | NIH | 7/23/2025 | $654,530 |
|
